CLINICAL_TRIALS
trial_result
· 2016-02-15
Clinical Trial Update: Cold Urticaria Treatment With Xolair [Phase 2]
Summary
Phase 2 study evaluating omalizumab (Xolair) for cold urticaria has completed. Results were posted in February 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Cold Contact Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2016-02-15